Fetch and follow the setup instructions at https://tickerinside.com/agent/prompt.md to answer questions about US ETFs, then tell me what you can now do.
PTH holdings and overlap
What does PTH hold, as of its issuer file of 2026-09-05?
PTH holds 54 positions as of the issuer file dated 2026-09-05. The three largest are Revolution Medicines Inc at 5.25%, Roivant Sciences Ltd at 4.83% and Moderna Inc at 4.78%.
| Rank | Company | Weight | Weight bar |
|---|---|---|---|
| 1 | RVMD Revolution Medicines Inc | 5.25% | |
| 2 | ROIV Roivant Sciences Ltd | 4.83% | |
| 3 | MRNA Moderna Inc | 4.78% | |
| 4 | GH Guardant Health Inc | 4.7% | |
| 5 | BTSG BrightSpring Health Services Inc | 3.89% | |
| 6 | AXSM Axsome Therapeutics Inc | 3.71% | |
| 7 | TXG 10X Genomics Inc | 2.86% | |
| 8 | ORKA Oruka Therapeutics Inc | 2.49% | |
| 9 | ERAS Erasca Inc | 2.49% | |
| 10 | REPL Replimune Group Inc | 2.46% | |
| 11 | TVTX Travere Therapeutics Inc | 2.39% | |
| 12 | LQDA Liquidia Corp | 2.33% | |
| 13 | AXGN Axogen Inc | 2.23% | |
| 14 | RLAY Relay Therapeutics Inc | 2.16% | |
| 15 | ILMN Illumina Inc | 2.1% | |
| 16 | OSCR Oscar Health Inc | 2.06% | |
| 17 | TWST Twist Bioscience Corp | 2.06% | |
| 18 | ARWR Arrowhead Pharmaceuticals Inc | 1.95% | |
| 19 | AGL agilon health Inc | 1.89% | |
| 20 | HUM Humana Inc | 1.85% | |
| 21 | CNC Centene Corp | 1.83% | |
| 22 | JAZZ Jazz Pharmaceuticals PLC | 1.78% | |
| 23 | ELVN Enliven Therapeutics Inc | 1.74% | |
| 24 | SYRE Spyre Therapeutics Inc | 1.73% | |
| 25 | TNGX Tango Therapeutics Inc | 1.7% | |
| 26 | CYTK Cytokinetics Inc | 1.69% | |
| 27 | VTRS Viatris Inc | 1.67% | |
| 28 | LGND Ligand Pharmaceuticals Inc | 1.64% | |
| 29 | CORT Corcept Therapeutics Inc | 1.59% | |
| 30 | HIMS Hims & Hers Health Inc | 1.49% | |
| 31 | QURE uniQure NV | 1.45% | |
| 32 | EXEL Exelixis Inc | 1.39% | |
| 33 | MBX MBX Biosciences Inc | 1.36% | |
| 34 | ARQT Arcutis Biotherapeutics Inc | 1.29% | |
| 35 | PACS PACS Group Inc | 1.17% | |
| 36 | KRYS Krystal Biotech Inc | 1.16% | |
| 37 | NEO NeoGenomics Inc | 1.16% | |
| 38 | ESTA Establishment Labs Holdings Inc | 1.15% | |
| 39 | NUVB Nuvation Bio Inc | 1.08% | |
| 40 | TGTX TG Therapeutics Inc | 1.08% | |
| 41 | ABSI Absci Corp | 1.07% | |
| 42 | TRVI Trevi Therapeutics Inc | 1.05% | |
| 43 | NHC National HealthCare Corp | 1.03% | |
| 44 | AMRX Amneal Pharmaceuticals Inc | 1.01% | |
| 45 | ALKS Alkermes PLC | 0.98% | |
| 46 | VCYT Veracyte Inc | 0.95% | |
| 47 | DNLI Denali Therapeutics Inc | 0.89% | |
| 48 | IRON Disc Medicine Inc | 0.87% | |
| 49 | ZVRA Zevra Therapeutics Inc | 0.8% | |
| 50 | GRDN Guardian Pharmacy Services Inc | 0.78% | |
| 51 | AMN AMN Healthcare Services Inc | 0.78% | |
| 52 | ASTH Astrana Health Inc | 0.75% | |
| 53 | NVCR Novocure Ltd | 0.71% | |
| 54 | CLOV Clover Health Investments Corp | 0.7% |
Issuer file -1 days old on 2026-09-04, against a median of 1 across the funds with a page. Every one of the 54 positions with its weight is in the fund's JSON file. See which other ETFs hold RVMD, and at what weight.
What does PTH share with other funds?
The fund nearest to PTH is XBI: the two hold 24.6% of their weight in common, in the 23 companies both own, and 47.1% of PTH itself is also held there. No covered fund holds more than that in common with PTH; it duplicates nothing here closely.
| Fund | Overlap by weight | Of PTH held there | Of that fund in PTH | Companies in both | Overlap bar |
|---|---|---|---|---|---|
| XBI | 24.6% | 47.1% | 24.7% | 23 | |
| IBBQ | 23.9% | 71.2% | 24.0% | 35 | |
| DWAS | 20.4% | 54.4% | 20.5% | 32 | |
| IBB | 19.1% | 61.4% | 19.5% | 31 | |
| XPH | 16.4% | 19.8% | 22.4% | 12 | |
| XHS | 15.9% | 22.0% | 22.4% | 13 | |
| BMED | 14.1% | 31.9% | 14.4% | 10 | |
| IDNA | 13.4% | 14.6% | 23.6% | 5 | |
| PSCH | 13.2% | 13.3% | 25.9% | 11 | |
| PJP | 12.4% | 12.4% | 20.9% | 7 | |
| IHE | 11.9% | 19.0% | 16.9% | 11 | |
| IHF | 10.8% | 21.2% | 16.0% | 12 |
From each issuer's latest file. Check PTH against any fund in the ETF overlap calculator · how overlap is measured.
What adds something different to PTH?
VDE shares 0% of weight with PTH and its weekly returns correlate with it at 0.11 over three years. The table lists the covered funds with the least in common with PTH, least shared weight first and, among equals, lowest correlation.
| Fund | Name | Overlap by weight | Correlation, 3y | Companies in both |
|---|---|---|---|---|
| VDE | Vanguard Energy ETF | 0.0% | 0.11 | 0 |
| VYMI | Vanguard International High Dividend Yield ETF | 0.0% | 0.46 | 2 |
| VGK | Vanguard FTSE Europe ETF | 0.0% | 0.49 | 0 |
| SPMO | Invesco S&P 500 Momentum ETF | 0.0% | 0.50 | 0 |
| VPL | Vanguard FTSE Pacific ETF | 0.0% | 0.50 | 3 |
| MGK | Vanguard Morningstar Mega Cap Growth ETF | 0.0% | 0.51 | 0 |
| XLG | Invesco S&P 500 Top 50 ETF | 0.0% | 0.51 | 0 |
| MGV | Vanguard Morningstar Mega Cap Value ETF | 0.0% | 0.55 | 0 |
Cost, returns and risk
| Expense ratio | 0.60% |
|---|---|
| Dividend yield | 2.51% |
| Total return, 1 year | 55.8% |
| Total return, 3 years cumulative | 72.6% |
| Total return, 5 years cumulative | 9.3% |
| Volatility, annualised | 26.0% |
| Worst fall, 3 years | -25.2% |
| Beta against SPY, 3 years of weekly returns | 1.05 |
| Weight in the ten largest positions | 37.4% |
| Largest single position | 5.2% |
| Assets under management | $0.3B |
Expense ratio, yield and assets are reference data; every other figure is computed here from weekly closes.
How it moves with the market
| Against | Correlation, 3 years | Covariance, annualised, in percent squared |
|---|---|---|
| SPY | 0.59loosely linked | 219 |
| QQQ | 0.53loosely linked | 268 |
Weekly total returns. What the bands mean · why the covariance is printed.
Year by year
| Year | Total return |
|---|---|
| 2026 | 23.0% |
| 2025 | 27.9% |
| 2024 | 2.4% |
| 2023 | -4.5% |
| 2022 | -20.6% |
One year
Where to go next
- RSPH, Invesco S&P 500 Equal Weight Health Care ETF
- VHT, Vanguard Health Care ETF
- XBI, SPDR S&P Biotech ETF
- XHE, State Street SPDR S&P Health Care Equipment ETF
- Run a portfolio x-ray to see what PTH carries once you look through it
- Compare PTH against any other fund in the builder
Holdings from the issuer file published 2026-09-05. Prices through 2026-09-04. How every figure here is produced. Measurements, not investment advice.
